Functional Responses and Apoptosis of CD25 (IL-2Rα)-Deficient T cells Expressing a Transgenic Antigen Receptor

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 3738-3745

  Van Parijs, Luk ^a   Biuckians, Andre ^a   Ibragimov, Alexander ^a,b   Alt, Frederick W ^c   Willerford, Dennis M ^c,d   Abbas, Abul K ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PFIZER INC   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e LMRC 521 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; GENETICS; IMMUNOLOGY; MOUSE; PATHOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0031569514     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
2. Mor, F., and I. R. Cohen. 1996. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis: correlation with induction of bcl-2. J. Immunol. 156:515.
3. + helper T cells: a model for the long-term survival of memory cells. J. Immunol. 156:1764.
4. + T cells. Annu. Rev. Immunol. 12:635.
5. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
6. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell 75:253.
7. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
8. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohasi, H. Griesser, T. Taniguchi, C. Paige, and T. W. Mak. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
9. Van Parijs, L., and A. K. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:355.
10. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
11. lo thymocytes in vivo. Science 250: 1720.
12. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
13. Perez, V. L., J. A. Lederer, A. H. Lichtman, and A. K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869.
14. Swain, S. L. 1991. Lymphokines and the immune response: the central role of interleukin-2. Curr. Opin. Immunol. 3:304.
15. LeGros, G. G., S. S. Ben-Sasson, R. F. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:920.
16. + T cells for IFN-γ but have differential effects on priming for IL-4. J. Immunol. 156:2413.
17. Tagaya, Y., R. N. Bamford, A. P. DeFillipis, and T. A. Waldmann. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression in controlled at multiple levels. Immunity 4:329.
18. L. Immunity 3:87.
19. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
20. Suda, T., T. Okazaki, Y. Naito, T. Yokoto, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of the T cell lineage. J. Immunol. 154:3806.
21. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513.
22. c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). Adv. Exp. Biol. Med. 365:225.
23. Kneitz, B., T. Herrman, S. Yonehara, and A. Schimpl. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy in IL-2 deficient mice. Eur. J. Immunol. 25:2572.
24. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
25. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
26. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynchi, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferalion and fatal multiorgan tissue destruction, revealing a critical regulatory role of CTLA-4. Immunity 3:541.
27. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.